The angiographic catheters market size is projected to cross USD 1,451.0 million in 2023 and is anticipated to hit a valuation of USD 2,215.4 million by 2033. The angiographic catheters market share is estimated to thrive at a CAGR of 4.3% from 2023 to 2033.
Heart disease and other cardiovascular conditions, such as coronary artery disease and peripheral artery disease, continue to be the primary drivers of morbidity and mortality across the globe. To diagnose and treat these disorders, angiographic catheters are often utilized in diagnostic and interventional procedures. The importance of early cardiovascular disease diagnosis and preventive treatment is rising. As a result, there are now more diagnostic methods available, such as angiography, which makes use of angiographic catheters, and facilitates industry expansion.
Track the Latest Market Developments: Request a Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d36303533
Due to its potential advantages, such as shorter hospital stays, quicker recovery periods, and lower complication rates, minimally invasive treatments like angiography are favored by patients and medical professionals. As the trend toward minimally invasive treatments continues, there is predicted to be a rise in demand for angiographic catheters. Several countries are making investments in fostering the development and growth of their healthcare infrastructure, which includes hospitals and specialized medical facilities. This investment stimulates the market for angiographic catheters and opens doors for the installation of angiography equipment.
With advancements like optical coherence tomography (OCT), intravascular ultrasound (IVUS), and 3D angiography, the field of medical imaging continues to grow quickly. These innovations offer clearer, more accurate pictures that aid in improved diagnosis and treatment planning. The use of such sophisticated imaging technologies frequently necessitates the use of expert angiographic catheters. Along with increased disposable incomes and better healthcare access, developing countries are experiencing growth in their healthcare infrastructure. The expansion of emerging markets offers exciting opportunities for industry participants to launch angiographic catheters and meet the rising demand.
Key Takeaways: Angiographic Catheters Market
- North America Dominates the Market:
With a 33.1% share in 2022, North America led the angiographic catheter market due to high adoption of advanced technologies and the strong presence of key players. Robust R&D investments and frequent new product launches continue to drive regional growth.
- Europe Shows Strong Growth Potential:
Western Europe accounted for 28.2% of the market in 2022, backed by government reimbursement support for coronary angioplasty procedures. An aging population and growing demand for sterile, disposable catheters further contribute to market expansion.
- Tech-Driven Innovation Fuels the Start-Up Ecosystem:
Emerging companies are leveraging cutting-edge technology to reshape the market. Notable examples include AngioSculpt by Angioscore (now part of Spectranetics) and Cleerly Coronary, which raised USD 43 million for its AI-powered heart imaging platform—highlighting a shift toward innovation in diagnosis and treatment.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report! https://www.futuremarketinsights.com/reports/angiographic-catheters-market
Competitive Landscape of the Angiographic Catheters Market
The angiographic catheters market remains highly fragmented, characterized by the presence of several key players and numerous smaller manufacturers. Recent advancements have focused on enhancing the surface properties of these catheters, aimed at improving performance and patient outcomes.
Recent Market Developments:
- Teleflex Incorporated announced in February 2022 that the U.S. Food and Drug Administration (FDA) approved an expanded indication for its specialty catheters and coronary guidewires, enabling their use in chronic total occlusion percutaneous coronary interventions (CTO PCI).
- In July 2023, Royal Philips introduced its new real-time 3D intracardiac echocardiography (ICE) device, which was used in the first minimally invasive heart procedure—Left Atrial Appendage Occlusion (LAAO)—performed by Dr. Mohamad Adnan Alkhouli at the Mayo Clinic in Minnesota, USA.
Leading Companies in the Global Angiographic Catheters Market:
- AngioDynamics Inc.
- Terumo Europe NV
- Medtronic
- Merit Medical Systems Inc.
- OSCOR Inc.
- B. Braun Melsungen AG
- Cardinal Health
- InSitu Technologies Inc.
- BVM Medical Limited
- Precision Extrusion Inc.
- Cardiva
- C. R. Bard Inc.
- Boston Scientific Corporation
Download Our Comprehensive Healthcare Industry Report! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device
Market Segmentation
By Product Type:
- Scoring Balloon Catheters
- Cutting Balloon Catheters
By End Use:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
